45 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... • Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS # ... IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Mycobacterium tuberculosis ... • Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS # ... IDSA #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Treatment: Active ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Treatment: Active ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
Adjuvant therapies in critical ... steroids to treat infectious ... meningitis - Tuberculous ... #Pharmacology #Management ... #Treatment #Indications
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
result with no clinical ... diagnosing and treating ... infection • Recent ... viral infections ... used to exclude pulmonary
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Preventing and Treating ... Treating Acute Infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... Clostridium difficile Infection ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
(Diffuse Pulmonary ... • Use until clinical ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Herpes Simplex Virus ... • Continue treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS